Evidence map›Paper›PMID 36384690›Full record

Observational studyPediatric rheumatology online journal2022

Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study.

Gerd Horneff, Julia Borchert, Ria Heinrich, Simon Kock, Pascal Klaus, Heike Dally, Christine Hagemann, Joanna Diesing, Tonio Schönfelder

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Pediatric rheumatology online journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Gerd HorneffDepartment of General Paediatrics, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany.
Julia BorchertScientific Institute for Health Economics and Health System Research (WIG2 GmbH), Leipzig, Germany.
Ria HeinrichScientific Institute for Health Economics and Health System Research (WIG2 GmbH), Leipzig, Germany.
Simon KockInstitute for Applied Health Research (InGef), Berlin, Germany.
Pascal KlausPfizer Pharma GmbH, Berlin, Germany.
Heike DallyPfizer Pharma GmbH, Berlin, Germany.
Christine HagemannPfizer Pharma GmbH, Berlin, Germany.
Joanna DiesingScientific Institute for Health Economics and Health System Research (WIG2 GmbH), Leipzig, Germany.
Tonio SchönfelderScientific Institute for Health Economics and Health System Research (WIG2 GmbH), Leipzig, Germany. tonio.schoenfelder@wig2.de.ORCID http://orcid.org/0000-0001-6158-4191
Pfizer (Germany) · DEAsklepios Klinik Sankt Augustin · DEInstitute for Applied Economic Research · DEResearch Institute for System Studies · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJuvenile idiopathic arthritis (JIA) describes heterogenous categories of chronic inflammatory rheumatic conditions of unknown origin in children and adolescents. Epidemiological data in the literature vary, depending on geographic location, ethnicity and the case definition used. We evaluated epidemiology, especially that of the categories defined by the International League of Associations for Rheumatology (ILAR).

methodsUsing data from two different longitudinal health claims databases (WIG2 and InGef) from January 1

resultsOf the 3-4 million patients in the databases (respectively) in 2018, we found a total of 546 (WIG2) and 849 (InGef) patients that met our JIA case definition, with an incidence of 34 (29-41) and 60 (53-67) and prevalence of 133 (122-145) and 168 (157-179). Both incidence and prevalence throughout the age range were mostly higher in females than males, however the difference between females and males increased with increasing age. Of the ILAR categories, oligoarthritis was the most prevalent (70 and 91 per 100,000), with about half of our JIA patients in this category, followed by undifferentiated arthritis (49 and 56 cases per 100,000) and rheumatoid factor negative (RF-) (31 and 39 per 100,000). Incidence in 2018 was the highest in these three categories. Atopic dermatitis, vasomotor and allergic rhinitis, and uveitis were the pre-defined comorbidities seen most often in both databases.

conclusionThis study provides current incidence and prevalence JIA data in Germany, contributing to knowledge on burden of disease and tools for healthcare planning.

Indexed as

Arthritis, JuvenileAdolescentChildChild, PreschoolFemaleGermanyHumansIncidenceMalePrevalenceRetrospective StudiesBurden of diseaseComorbiditiesIncidenceJIAJuvenile idiopathic arthritisPolyarticular JIAPrevalence

Identifiers

PMID36384690
PMCPMC9670409
OpenAlexW4309144612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.